Financial statements Naturalantibody
Cash inflows of NATURALANTIBODY
Year
|
2020
|
2022
|
2023
|
---|---|---|---|
Net cash from operating expenses | -754 545,93 | -3 899 632,97 | -4 258 105,26 |
Net cash flow from investing activities | -6 700,00 | -48 090,24 | 0,00 |
Net cash flow from financial activities | 3 150 003,00 | 3 776 955,05 | 3 768 460,78 |
Total net cash flow | 2 388 757,07 | -170 768,16 | -489 644,48 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.